Therefore, bacterial-induced secretion of FGF21 is effective in maintaining the integrity of the cerebral cortex and reducing cortical atrophy in the chronic phase after ischemic stroke, with long-term effectiveness. This evidence concerns the gene FGF21 and ischemic stroke.